Masanobu Uchiyama, Motoyasu Miyazaki, Toshinobu Hayashi, Mototsugu Shimokawa, Takafumi Nakano, Hideki Kakimoto, Satoko Takaki, Haruka Fukue, Takafumi Inoue, Ryuichi Inoue, et al. Assessing the ability of the Cancer and Aging Research Group tool to predict chemotherapy toxicity in older Japanese patients: A prospective observational study. Journal of geriatric oncology. 2024. 15. 6. 101814-101814
Hajime Nakashima, Motoyasu Miyazaki, Tsuneo Kuwamura, Kazutaka Oda, Yumi Haga, Osamu Imakyure. Relationship between Target Time above Minimum Inhibitory Concentration Achievement Rate of Meropenem Using Monte Carlo Simulation and In-Hospital Survival in Patients with Pseudomonas aeruginosa Bacteremia. Antibiotics. 2024. 13. 3. 219-219
Kou Masaki,Motoyasu Miyazaki,Hideki Kakimoto,Yuma Fukiage,Haruka Fukue,Akio Nakashima,Osamu Imakyure. Incidence and Timing of Immune-Related Adverse Events in Immune-Checkpoint Inhibitor-Treated Patients: A Retrospective Observational Study. Journal of Clinical Medicine. 2023. 12. 23. 7564
Haruka Fukue, Masanobu Uchiyama, Motoyasu Miyazaki, Koichi Matsuo, Osamu Imakyure, Hideki Kakimoto, Emi Nishida, Akane Nagasato, Susumu Kaneshige, Kentaro Ogata, et al. Selection of a generic version of oxaliplatin based on the time-dependent change of PH value. Japanese Pharmacology and Therapeutics. 2019. 47. 121-125